Among the isoflavones, genistein was reported to ameliorate the Aβ-induced impairments responsible for neuronal death in AD animal models by exerting antioxidant activity, abating Aβ toxicity, inhibiting nitric oxide (NO) generation, and reducing tau pathology [90,91]. The gene discussed is MAPT; the disease is Alzheimer disease.